← All companies
AVNS
Avanos Medical Inc
$24.99
+0.01 +0.04%
Key statistics
from XBRL data in SEC filingsMarket cap
$1.17B
Revenue (TTM)
$716M
Net income (TTM)
-$74.4M
EPS (TTM)
$-1.60
P/E ratio
—
Dividend yield
—
Free cash flow
$43.1M
Cash
$65.6M
Total assets
$1.05B
Gross margin
50.0%
52-week range
$9.30 – $25.49
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Entered a material agreement; Terminated a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Delisting notice or listing-rule failure; Modified rights of security holders; Change in control; Director or officer change; Amended charter or bylaws; Regulation FD disclosure
Jul 30, 2026
8-K
Shareholder vote results; Regulation FD disclosure
Jul 22, 2026
8-K
Other events
Jul 15, 2026
8-K
Regulation FD disclosure
Jul 2, 2026
10-Q
Quarter ended 2026-03-31
May 5, 2026
8-K
Results of operations (earnings release)
May 5, 2026
8-K
Entered a material agreement; Regulation FD disclosure
Apr 14, 2026
8-K
Director or officer change
Mar 12, 2026
8-K
Entered a material agreement; Other events
Feb 26, 2026
10-K
Fiscal year ended 2025-12-31
Feb 24, 2026
8-K
Results of operations (earnings release)
Feb 24, 2026
8-K
Regulation FD disclosure
Jan 13, 2026
8-K/A
Director or officer change
Dec 5, 2025
10-Q
Quarter ended 2025-09-30
Nov 5, 2025
8-K
Results of operations (earnings release)
Nov 5, 2025
8-K
Director or officer change
Oct 23, 2025
8-K
Regulation FD disclosure
Sep 15, 2025
10-Q
Quarter ended 2025-06-30
Aug 5, 2025
8-K
Results of operations (earnings release); Director or officer change; Regulation FD disclosure
Aug 5, 2025
10-Q
Quarter ended 2025-03-31
May 6, 2025
8-K
Results of operations (earnings release)
May 6, 2025
8-K
Director or officer change
Apr 30, 2025
8-K/A
Director or officer change
Apr 28, 2025
8-K
Shareholder vote results
Apr 25, 2025
8-K
Director or officer change
Apr 18, 2025
8-K/A
Director or officer change; Regulation FD disclosure
Apr 18, 2025
8-K
Director or officer change; Regulation FD disclosure
Mar 17, 2025
10-K
Fiscal year ended 2024-12-31
Feb 26, 2025
8-K
Results of operations (earnings release)
Feb 26, 2025
8-K
Regulation FD disclosure
Jan 13, 2025
8-K
Director or officer change
Dec 3, 2024
8-K
Other events
Nov 4, 2024
10-Q
Quarter ended 2024-09-30
Oct 30, 2024
8-K
Results of operations (earnings release); Director or officer change
Oct 30, 2024
10-Q
Quarter ended 2024-06-30
Jul 31, 2024
8-K
Results of operations (earnings release)
Jul 31, 2024
8-K
Director or officer change; Regulation FD disclosure
Jul 1, 2024
8-K
Regulation FD disclosure
May 13, 2024
10-Q
Quarter ended 2024-03-31
May 2, 2024
8-K
Results of operations (earnings release)
May 2, 2024